Login
$AMLX
$27.67 -$0.13 (0.47%) After hours

Insider Transactions

What Amylyx Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 2
Sells 19 39
Total trades 28 60

Shares traded

3 months 12 months
Acquired 276,976 1,453,246
Disposed 361,302 831,975
Net activity −84,326 +621,271

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Frates James M Chief Financial Officer Nov 10 Open-market sale · S −7,200 $30.97 −$223K 233,625
Frates James M Chief Financial Officer Nov 10 Open-market sale · S −12,800 $30.32 −$388K 240,825
Frates James M Chief Financial Officer Nov 10 Exercise / conversion · M +20,000 $6.88 +$138K 253,625
Cohen Joshua B Co-Chief Executive Officer Nov 09 Open-market sale · S −61,895 $30.11 −$1.86M 3,513,123
Cohen Joshua B Co-Chief Executive Officer Nov 09 Open-market sale · S −38,105 $29.39 −$1.12M 3,575,018
Frates James M Chief Financial Officer Nov 09 Open-market sale · S −12,300 $30.11 −$370K 233,625
Frates James M Chief Financial Officer Nov 09 Open-market sale · S −7,700 $29.39 −$226K 245,925
Frates James M Chief Financial Officer Nov 09 Exercise / conversion · M +20,000 $6.88 +$138K 253,625
Klee Justin B. Co-Chief Executive Officer Nov 09 Open-market sale · S −62,517 $30.11 −$1.88M 3,513,056
Klee Justin B. Co-Chief Executive Officer Nov 09 Open-market sale · S −37,483 $29.39 −$1.1M 3,575,573
Milne George M Jr Director Oct 05 Open-market sale · S −30,000 $27.70 −$831K 782,881
Frates James M Chief Financial Officer Sep 10 Open-market sale · S −1,042 $33.23 −$34.6K 233,625
Frates James M Chief Financial Officer Sep 10 Open-market sale · S −9,768 $32.27 −$315K 234,667
Klee Justin B. Co-Chief Executive Officer Sep 10 Open-market sale · S −1,439 $33.16 −$47.7K 3,613,056
Klee Justin B. Co-Chief Executive Officer Sep 10 Open-market sale · S −29,025 $32.13 −$933K 3,614,495
Cohen Joshua B Co-Chief Executive Officer Sep 10 Open-market sale · S −919 $33.15 −$30.5K 3,613,123
Cohen Joshua B Co-Chief Executive Officer Sep 10 Open-market sale · S −29,545 $32.16 −$950K 3,614,042
Bedrosian Camille L Chief Medical Officer Sep 10 Open-market sale · S −2,081 $33.09 −$68.9K 278,064
Bedrosian Camille L Chief Medical Officer Sep 10 Open-market sale · S −7,947 $32.21 −$256K 280,145
Mazzariello Gina Chief Legal Officer Sep 10 Open-market sale · S −11 $33.34 −$367 190,838

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support